RBC Capital Maintains Outperform on Exelixis, Raises Price Target to $28
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Gregory Renza has maintained an Outperform rating on Exelixis (NASDAQ:EXEL) and increased the price target from $26 to $28.
February 07, 2024 | 5:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital analyst Gregory Renza has reaffirmed an Outperform rating on Exelixis and raised the price target from $26 to $28.
The increase in price target by a reputable analyst like Gregory Renza suggests a positive outlook on Exelixis's future performance. This endorsement is likely to instill confidence in investors, potentially driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100